Skip to content

Hip Arthroscopy Study

Arthroscopic intervention in patients with femoroacetabular impingement or acetabulum labrum tears: long term functional outcome results

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON27033
Enrollment
Unknown
Registered
2017-11-03
Start date
2015-02-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hip arthroscopy, femoroacetabular impingement, acetabulum labrum tears

Interventions

Patients undergo routine physical examination before surgery and at 3 months and 12 months after surgery. They will also complete questionnaires (consisting of Hip Outcome Survey, iHOT12-NL, VAS, EQ-5

Sponsors

Reinier de Graaf Groep, afdeling orthopedie
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients who: - Are 15-65 years of age. - Have a physical examination, which is suspect for femoroacetabular impingment, or an acetabulum labrum tear or lesion, or are suspect to loose bodies in the hip joint, chondral lesions or osteophytes impingement. - Have no contraindications for MRI. - Are willing to return for regular evaluation visits.

Exclusion criteria

Exclusion criteria: Patients who: - Are 65 years of age. - Have had prior surgery for femoroacetabular impingement. - Complaints caused by other diagnoses than the ones in inclusion criteria. - Have pathological fractures or other metastatic pathology as a cause of the hip/groin pain.

Design outcomes

Primary

MeasureTime frame
The main parameters are: - Functional outcome; measured by the modified Harris Hip Score - Improvement of pain; measured by the EQ-5D - Complications rate; recorded in minor and major complications

Secondary

MeasureTime frame
The secondary parameters are: - Risk factors for failure of treatment, amongst which the alpha angle on x-ray Lauenstein

Contacts

Public ContactN.M.C. Mathijssen

Reinier de Graafweg 3-11

N.Mathijssen@rdgg.nl+31 (0)15 2603718

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)